HFA recognizes and supports efforts to further the development and availability of promising HCV therapies for the bleeding disorders community. Click here to read the recent letter to FDA Commissioner, Dr. Margaret Hamburg. Click here to read the MASAC Recommendations for Treatment of Chronic HCV Infection.

Sign up for E-mails, Dateline Magazine, and other ways to stay connected.